XERS
Xeris Biopharma Holdings Inc

10,563
Mkt Cap
$1.16B
Volume
1.72M
52W High
$10.08
52W Low
$3.14
PE Ratio
-69.34
XERS Fundamentals
Price
$7.17
Prev Close
$7.01
Open
$7.09
50D MA
$8.00
Beta
1.38
Avg. Volume
2.94M
EPS (Annual)
-$0.3736
P/B
-1,378.85
Rev/Employee
$515,406.09
Loading...
Loading...
News
all
press releases
Walleye Capital LLC Sells 448,444 Shares of Xeris Biopharma Holdings, Inc. $XERS
Walleye Capital LLC reduced its holdings in Xeris Biopharma Holdings, Inc. (NASDAQ:XERS - Free Report) by 64.8% during the 2nd quarter, according to its most recent filing with the Securities and...
MarketBeat·2d ago
News Placeholder
More News
News Placeholder
561,700 Shares in Xeris Biopharma Holdings, Inc. $XERS Bought by Norges Bank
Norges Bank purchased a new stake in Xeris Biopharma Holdings, Inc. (NASDAQ:XERS - Free Report) during the second quarter, according to the company in its most recent filing with the Securities and...
MarketBeat·2d ago
News Placeholder
Xeris Biopharma (NASDAQ:XERS) Insider Sells $116,835.67 in Stock
Xeris Biopharma Holdings, Inc. (NASDAQ:XERS - Get Free Report) insider Beth Hecht sold 16,667 shares of the firm's stock in a transaction on Monday, December 1st. The stock was sold at an average...
MarketBeat·9d ago
News Placeholder
Oversold Conditions For Xeris Biopharma Holdings (XERS)
Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a...
Nasdaq News: Markets·11d ago
News Placeholder
Xeris Announces Notice of Allowance from U.S. Patent and Trademark Office for XP-8121 Patent Application
Xeris Biopharma Holdings, Inc. (Nasdaq: XERS), a fast-growing biopharmaceutical company committed to improving patient lives by developing and commercializing innovative products across a range of...
Business Wire·12d ago
News Placeholder
Prudential Financial Inc. Buys 457,784 Shares of Xeris Biopharma Holdings, Inc. $XERS
Prudential Financial Inc. grew its stake in shares of Xeris Biopharma Holdings, Inc. (NASDAQ:XERS - Free Report) by 41.7% in the second quarter, according to its most recent disclosure with the SEC...
MarketBeat·12d ago
News Placeholder
Xeris Biopharma Holdings, Inc. $XERS Shares Acquired by CenterBook Partners LP
CenterBook Partners LP increased its holdings in shares of Xeris Biopharma Holdings, Inc. (NASDAQ:XERS - Free Report) by 237.7% in the 2nd quarter, according to the company in its most recent Form...
MarketBeat·20d ago
News Placeholder
Xeris Biopharma (NASDAQ:XERS) Insider Sells $173,385.32 in Stock
Xeris Biopharma Holdings, Inc. (NASDAQ:XERS - Get Free Report) insider John Patrick Shannon, Jr. sold 23,242 shares of Xeris Biopharma stock in a transaction on Thursday, November 13th. The shares...
MarketBeat·24d ago
News Placeholder
Insider Selling: Xeris Biopharma (NASDAQ:XERS) Insider Sells 23,242 Shares of Stock
Xeris Biopharma Holdings, Inc. (NASDAQ:XERS - Get Free Report) insider John Patrick Shannon, Jr. sold 23,242 shares of the business's stock in a transaction on Thursday, November 13th. The shares...
MarketBeat·25d ago
News Placeholder
Leerink Partnrs Forecasts Xeris Biopharma FY2025 Earnings
Xeris Biopharma Holdings, Inc. (NASDAQ:XERS - Free Report) - Equities researchers at Leerink Partnrs increased their FY2025 earnings per share estimates for shares of Xeris Biopharma in a report...
MarketBeat·26d ago

Latest XERS News

View

Advertisement|Remove ads.

Advertisement|Remove ads.